Pharmacologically active: clinical trials and the pharmaceutical industry
SOURCE: South African Medical Journal
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2008
TITLE AUTHOR(S): M.Kahn, M.Gastrow
KEYWORDS: PHARMACEUTICAL INDUSTRY, RESEARCH AND DEVELOPMENT (R&D)
Print: HSRC Library: shelf number 5072
HANDLE: 20.500.11910/9134
URI: http://hdl.handle.net/20.500.11910/9134
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2008
TITLE AUTHOR(S): M.Kahn, M.Gastrow
KEYWORDS: PHARMACEUTICAL INDUSTRY, RESEARCH AND DEVELOPMENT (R&D)
Print: HSRC Library: shelf number 5072
HANDLE: 20.500.11910/9134
URI: http://hdl.handle.net/20.500.11910/9134
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
Multinational pharmaceutical companies ('pharma's') import and produce pharmaceuticals and also conduct clinical trials which are an important aspect of research and development (R&D). This may raise the question: Is South Africa a guinea pig for the pharma's? The Department of Trade and Industry National Industrial Policy Framework designates chemicals, plastic fabrication and pharmaceuticals as a key value chain. So a second question could be: Can South Africa be a manufacturer for the pharma's, or can it leverage strengths in medical research and the conducting of clinical trials so as to develop a discovery-led industry? This paper analyses and quantifies the state of the clinical trials industry in South Africa, and concludes that: (i) a sizeable clinical trials industry exists, and that these trials are predominantly phase 3 and global in scope; (ii) South Africa is not a specific or unique guinea pig - a range of conditions is studied as part of global trials; and (iii) while South Africa has excellent prospects for increased clinical trials activity, R&D investment is too low to make it a major pharmaceutical contender.-
Related Research Outputs:
- National survey of research and experimental development (R&D) (2001/2): High-level key results
- Flight of the flamingos: a study on the mobility of R&D workers
- South African research and development: preliminary results and indicators from the latest survey
- Developments in R & D in post-colonial South Africa: findings from a recent national survey
- What's happening to R&D?
- South African study on the mobility of R&D workers - implications for the project on careers of doctorate holders
- The changing face of South Africa's national system of innovation, 1991-2001
- The knowledge of numbers: S&T, R&D and innovation indicators in South Africa
- Supply to the R&D system: broadening the base
- The history of research and experimental development measurement in South Africa and some current perspectives
- The changing nature of research and development inputs in the South African higher education sector: findings from the national research and experimental development survey
- Open for business: observations on the R&D behavior of South African firms
- Measuring innovation in OECD and non-OECD countries: selected seminar papers
- The state of research and experimental development: moving to a higher gear
- The noledge of numbers: S&T, R&D and innovation indicators in South Africa
- National survey of research and experimental development (R&D) (2003/04 fiscal year): high-level key results
- National survey of research & development 2003/2004: provisional report on the sectors
- R & D matters
- Progress with the South African Innovation survey 2005
- After apartheid: the South African national system of innovation: from constructed crisis to constructed advantage?